-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Mural Oncology plc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2022 to Q2 2024.
- Mural Oncology plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$34.3M, a 27.5% increase year-over-year.
- Mural Oncology plc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$173M.
- Mural Oncology plc annual Operating Income (Loss) for 2023 was -$196M, a 6.12% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)